Back to Search
Start Over
Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.
- Source :
-
The Lancet. Oncology [Lancet Oncol] 2019 Jan; Vol. 20 (1), pp. e29-e41. - Publication Year :
- 2019
-
Abstract
- Childhood, adolescent, and young adult (CAYA) cancer survivors treated with platinum-based drugs, head or brain radiotherapy, or both have an increased risk of ototoxicity (hearing loss, tinnitus, or both). To ensure optimal care and reduce consequent problems-such as speech and language, social-emotional development, and learning difficulties-for these CAYA cancer survivors, clinical practice guidelines for monitoring ototoxicity are essential. The implementation of surveillance across clinical settings is hindered by differences in definitions of hearing loss, recommendations for surveillance modalities, and remediation. To address these deficiencies, the International Guideline Harmonization Group organised an international multidisciplinary panel, including 32 experts from ten countries, to evaluate the quality of evidence for ototoxicity following platinum-based chemotherapy and head or brain radiotherapy, and formulate and harmonise ototoxicity surveillance recommendations for CAYA cancer survivors.<br /> (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Subjects :
- Adolescent
Antineoplastic Agents therapeutic use
Child
Cranial Irradiation adverse effects
Evidence-Based Medicine
Humans
Neoplasms radiotherapy
Ototoxicity etiology
Ototoxicity therapy
Platinum Compounds adverse effects
Population Surveillance
Young Adult
Antineoplastic Agents adverse effects
Cancer Survivors statistics & numerical data
Delivery of Health Care standards
Neoplasms drug therapy
Ototoxicity diagnosis
Ototoxicity prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1474-5488
- Volume :
- 20
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- The Lancet. Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 30614474
- Full Text :
- https://doi.org/10.1016/S1470-2045(18)30858-1